Related Experiment Video
Updated: Mar 7, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Platelets and von Willebrand factor in atherogenesis
Melinda D Wu1,2, Tamara M Atkinson1,3, Jonathan R Lindner1,4
1Knight Cardiovascular Institute, and.
Platelets are key in heart attack and stroke. New evidence shows platelet-endothelial interactions drive early atherosclerosis, with von Willebrand factor being a potential therapeutic target.
Area of Science:
- Cardiovascular Biology
- Hematology
- Atherosclerosis Research
Background:
- Platelet adhesion, activation, and aggregation are critical in acute atherothrombotic events like myocardial infarction and stroke.
- Emerging evidence implicates platelet-endothelial interactions in the initiation and progression of atherosclerotic plaques.
- Platelet-derived factors influence the proinflammatory and mitogenic state of mural cells.
Purpose of the Study:
- To explore the role of platelet-endothelial interactions in early atherogenesis.
- To identify key molecular mechanisms driving these interactions.
- To evaluate potential therapeutic targets for preventing early atherosclerotic plaque development.
Main Methods:
- Review of existing literature on platelet function and endothelial interactions.
- Analysis of mechanisms involving platelet glycoproteins, integrins, and von Willebrand factor.
- Discussion of therapeutic implications for early atherogenesis.
Main Results:
- Platelet-endothelial interactions contribute significantly to the early stages of atherosclerosis.
- Platelet-derived factors promote a proinflammatory and mitogenic environment for mural cells.
- Endothelial-associated von Willebrand factor, especially in multimerized form, is a major mediator of these interactions.
Conclusions:
- Platelet-endothelial interactions are crucial in initiating and growing atherosclerotic plaques.
- Multimerized von Willebrand factor is a significant factor and a promising therapeutic target.
- Targeting these interactions may offer novel strategies for managing early atherogenesis.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

